Survey: Most Americans believe it’s normal for women to experience pain and incontinence post-childbirth

Two years have passed since the US Supreme Court’s decision in Dobbs vs Jackson Women’s Health to overturn the constitutional protection for abortion rights. With

Biosygen also has two other T-cell therapies in Phase I/II clinical development. Image Credit: Juan Gaertner / Shutterstock. Biosyngen received an all-clear from the US

Share this article Figure 1: Total deal value by deal therapy area of licensing agreements for innovator drugs utilising the CRISPR system, globally, 2019-2024, year